June 07, 2017 | Larry Roberts
New Position Recognizes Her Impact on Growth, Stability and Reputation of Department’s Clinical Enterprise
Bankole A. Johnson, DSc, MD, MBChB, The Dr. Irving J. Taylor Professor and Chair for the Department of Psychiatry, Professor of Pharmacology, Anatomy and Neurobiology, along with UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Jill RachBeisel, MD, Associate Professor of Psychiatry, has been named Vice Chair for Clinical Affairs for the UM SOM Department of Psychiatry, commencing at the start of the next academic year.
Dr. RachBeisel, who also served as Division Head of Community Psychiatry as well as Chief of Clinical Services, brings to the position extensive clinical, teaching, research collaboration and administrative leadership over the past 24 years.
“Dr. RachBeisel has played an integral role in the tremendous growth of our clinical services in Psychiatry and is ideally suited to become our new Vice Chair of Clinical Affairs,” said Professor Johnson, who is also Director of the UM SOM Brain Science Research Consortium Unit.
In her new position, she will oversee the clinical operations of all programs within the Department of Psychiatry, which includes the coordination of seven major clinical Divisions: Adult, Alcohol and Drug Abuse, Child and Adolescent, Community, Consultation-Liaison, Geriatrics, and FPI practices. Among the new initiatives she will manage is the establishment of a Women‘s Mental Health Program, which is collaboration with the Departments of OB/GYN, Family Medicine and Pediatrics as well as with divisions within the Department of Psychiatry.
“As the Vice Chair of Clinical Affairs of the Department of Psychiatry, I see coordinating the mission of the hospital of UMMC, UMMS, and UMB as a major priority,” said Dr. RachBeisel. “I will be focusing on population health initiatives, the new challenges of the global budget, and the increasing demands for mental health and behavioral health services.”
Dr. RachBeisel began her career in the field of acute psychiatric care, emergency psychiatric interventions and quality management in the hospital setting.
During her tenure in Community Psychiatry, she developed a skills based teaching program for individuals with serious mental illness (SMI) living in supervised transitional housing. Her Curriculum, entitled “Academy of Independent Living,” is designed to prepare persons with SMI to live independently.
In addition, she is actively involved in understanding the impact of Population Health Management on persons with SMI as well as mental health issues in complex medical/surgical conditions.
“With Dr. RachBeisel’s strong research and clinical background in Adult Psychiatry, Serious and Persistent Mental Illness, substance abuse disorders and women’s mental health, she brings clinical leadership to areas of critical importance to our patients,” said Dean Reece, who is also Vice President for Medical Affairs at the University of Maryland the John Z. and Akiko K. Bowers Distinguished Professor. “We are delighted that she is taking on this new senior role in the Department of Psychiatry.”
Dr. RachBeisel is a graduate of the Pennsylvania State University School of Medicine where she received her medical degree in 1985. She completed her 4 year Psychiatric Residency Program, serving as Chief Resident in her 4th year from the University of Maryland Medical Center Psychiatric Residency Program in 1989.
About the University of Maryland School of Medicine
Celebrating its 210th Anniversary, the University of Maryland School of Medicine was chartered in 1807 and is the first public medical school in the United States and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Maryland’s Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global presence, with research and treatment facilities in more than 35 countries around the world. medschool.umaryland.edu/
Learn More
Contact
Department of Anesthesiology
(410) 328-6120 (phone)
(410) 328-5531 (fax)
newsletter@som.umaryland.edu
University of Maryland School of Medicine
Larry Roberts
Web Communications
410-706-4939
lroberts@som.umaryland.edu
Related stories
Tuesday, December 19, 2023
UM School of Medicine Review Highlights Rise in Psychiatric Disorders Linked to Increased Cannabis Use
The widespread use of cannabis (marijuana) and its increased potency are associated with a rise in cannabis-related psychiatric conditions, according to a new University of Maryland School of Medicine (UMSOM) review article that was recently published in the New England Journal of Medicine. It highlights the urgent need for doctors to screen for and treat patients who are experiencing symptoms of cannabis use disorder, which means they are experiencing significant problems from their use of the drug.
Friday, December 08, 2023
UM School of Medicine Celebrates the Life and Legacy of Former Psychiatry Chair, John A. Talbott, MD
It is with deep sorrow that we announce the news of the passing of internationally renowned psychiatrist John A. Talbott, MD, former Chair of Psychiatry and Professor Emeritus at the University of Maryland School of Medicine (UMSOM).
Friday, January 06, 2023
UM School of Medicine Scientists Create First Extensive Brain Cell Data Repository
Neuroscience researchers now have access to 50 million brain cells to better understand how the brain develops and functions or changes with disease or trauma. Last month, scientists at the University of Maryland School of Medicine’s (UMSOM) Institute for Genome Sciences (IGS) unveiled a “one-stop shop” for brain cell data called the Neuroscience Multi-Omic Archive (NeMO Archive). This archive is now available to neuroscience researchers to transform their understanding of the complex workings of the brain.
Tuesday, August 30, 2022
Effects of Drugs in Mice can Depend on the Sex of the Human Experimenter
University of Maryland School of Medicine researchers demonstrated that a stress response in the brain is essential for ketamine’s antidepressant response in mice suggesting new ways to improve antidepressant therapy for patients who do not respond to the treatment.
Tuesday, May 10, 2022
Longtime Academic and Clinical Affairs Leader, Department Chair, and Faculty Member, Tony Lehman, MD, Announces Retirement
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that Anthony Lehman, MD, MSPH, who served the UMSOM for more than 30 years as Senior Associate Dean for Clinical Affairs, Department Chair, and distinguished faculty member in the UMSOM Department of Psychiatry, will retire, effective June 30, 2022.
Thursday, September 23, 2021
Dr. Deanna Kelly Appointed New Chair of Institutional Review Board for the Maryland Department of Health
Deanna Kelly, PharmD, Professor of Psychiatry at the University of Maryland School of Medicine (UMSOM), has been appointed to lead the prestigious committee of experts who review and approve all proposed research projects involving human participants for the Maryland Department of Health (MDH). She will chair the MDH Institutional Review Board (IRB) for the next four years, a position she started in July.
Wednesday, May 05, 2021
Three Leading UMSOM Faculty Named Among Maryland's Top 100 Women
The Maryland Daily Record has named three leading faculty members at the University of Maryland School of Medicine to its 2021 listing of Maryland’s Top 100 Women. The three-- Tracy L. Bale, PhD, Professor of Pharmacology; Kimberly Lumpkins, MD, MBA, Associate Professor of Surgery; and Jill RachBeisel, MD, the Dr. Irving J. Taylor Professor and Chair of Psychiatry—were chosen for their “outstanding achievements demonstrated through professional accomplishments, community leadership and mentoring,” according to the publication.
Wednesday, February 03, 2021
Clinical and Academic Leader, Dr. Jill RachBeisel, Appointed Chair of the Department of Psychiatry at the UM School of Medicine
University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that Jill RachBeisel, MD, Associate Professor of Psychiatry, has been appointed to serve as the Chair of the Department of Psychiatry, effective immediately. Dr. RachBeisel has served as the Department’s Interim Chair for the past two years and was previously Acting Chair and Vice Chair of the Department. A prominent leader at UMSOM, she has garnered tremendous support among faculty and staff for her efforts to forge partnerships among various entities in an effort to strengthen mental health services provided to patients and the community at large. Dr. RachBeisel will be named The Dr. Irving J. Taylor Endowed Professor and Chair, Department of Psychiatry, when she is invested March 18.
Thursday, February 27, 2020
UMSOM Department of Psychiatry Creates New Position to Strengthen and Support Research Program
Jill RachBeisel, MD, Interim Chair of the Department of Psychiatry at the University of Maryland School of Medicine (UMSOM), along with UMSOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Gloria Reeves, MD, Associate Professor of Psychiatry, has been appointed to serve as the Vice Chair for Research of the Department.
Thursday, January 16, 2020
University of Maryland School of Medicine Research Shows That Older Patients With Untreated Sleep Apnea Need Greater Medical Care
Obstructive sleep apnea (OSA) is a common and costly medical condition leading to a wide range of health risks such as cardiovascular disease, stroke, depression, diabetes and even premature death. Researchers at the University of Maryland School of Medicine (UMSOM) found that the medical costs are substantially higher among older adults who go untreated for the disorder.
Wednesday, October 16, 2019
Researchers Discover Potential Therapy to Treat Detrimental Effects of Marijuana in Pre-Adolescent Individuals Exposed to THC in Womb
As a growing number of U.S. states legalize the medicinal and recreational use of marijuana, an increasing number of American women are using cannabis before becoming pregnant and during early pregnancy often to treat morning sickness, anxiety, and lower back pain. Although emerging evidence indicates that this may have long-term consequences for their babies’ brain development, how this occurs remains unclear.
Thursday, April 04, 2019
Mobile Addiction Treatment Unit Serves Maryland Eastern Shore
Health and addiction treatment officials from the Caroline County Health Department, Maryland Department of Health, the Maryland Opioid Operational Command Center, and the University of Maryland School of Medicine (UMSOM) in Denton, MD., launched the Eastern Shore Mobile Care Collaborative (ESMCC), a mobile system designed to provide state-of-the-art treatment for opioid disorders for those in need on the Maryland Eastern shore.
Wednesday, March 27, 2019
UMSOM Researchers Discover a Critical Receptor Involved in the Response to Fast-Acting Antidepressants Like Ketamine
Effective treatment of clinical depression remains a major mental health issue, with roughly 30 percent of patients who do not respond to any of the available treatments. Researchers at the University of Maryland School of Medicine (UMSOM) have discovered a crucial receptor called mGlu2 that is critical to the mechanism of fast-acting antidepressants such as ketamine when used to treat depression.
Thursday, November 08, 2018
Clinical Affairs Leader and Educator Dr. David B. Schwartz Announces Retirement from UM School of Medicine
University of Maryland School of Medicine Senior Associate Dean for Clinical Affairs, Anthony Lehman, MD, along with UMSOM Dean E. Albert Reece, MD, PhD, MBA, announced today that David B. Schwartz, MD, Director of Clinical Affairs Special Programs and Clinical Professor in the Department of Obstetrics and Gynecology’s Division of Maternal Fetal Medicine, will retire at the end of year.
Tuesday, October 16, 2018
Bankole A. Johnson Receives Prestigious American Society of Addiction Medicine Award
Bankole Johnson, DSc, MD, the Dr. Irving J. Taylor Professor and Chair of the Department of Psychiatry at the University of Maryland School of Medicine (UMSOM), has been named to receive the American Society of Addiction Medicine’s (ASAM) R. Brinkley Smithers Distinguished Scientist Award.
Friday, January 05, 2018
Fighting Opioid Addiction from Baltimore to Garrett County: University of Maryland School of Medicine Rises to the Challenge
The opioid epidemic has been deadly for Maryland. In 2016, more than 2000 people in the state died from overdoses; in 2017, deaths rose another 40 percent, and deaths from the powerful synthetic opioid fentanyl were up nearly 140 percent. Last year, Gov. Larry Hogan declared a state of emergency in response to the opioid epidemic, saying the state needs an “all-hands-on-deck approach.”